Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Huet

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Research in Structural Biology|January 19, 2026
Molecular determinants of TNFR1:TNFα binding and dynamics in a physiological membrane environmentElena Álvarez Sánchez, Simon Huet, Stéphane Téletchéa
Journal of Molecular Recognition : JMR|December 15, 2025
Energetics Decomposition of Sac7d:DNA Decrypts Amino Acids Role Without DNA Sequence SelectivityElena Álvarez-Sánchez, Bernard Offmann, Simon Huet, et al.
Plos One|November 6, 2015
Use of the Nanofitin Alternative Scaffold as a GFP-Ready Fusion TagSimon Huet, Harmony Gorre, Anaëlle Perrocheau, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 31, 2023
Inhalable Nanofitin demonstrates high neutralization of SARS-CoV-2 virus via direct application in respiratory tractSébastien Viollet, Elise Enouf, Justine Picot, et al.
Pharmaceutics|January 23, 2024
Enhancing Oral Delivery of Biologics: A Non-Competitive and Cross-Reactive Anti-Leptin Receptor Nanofitin Demonstrates a Gut-Crossing Capacity in an Ex Vivo Porcine Intestinal ModelSolene Masloh, Anne Chevrel, Maxime Culot, et al.
Journal of the American Chemical Society|March 17, 2026
Phenotyping by Molecular Mobility: Low-Affinity Reversible Probes Enable Characterizing and Classifying Cells Populations by Single-Molecule ImagingRoger Riera, Laurence W Fitzpatrick, Simon Huet, et al.
Molecular Cancer Therapeutics|August 14, 2023
Targeted Nanofitin-drug Conjugates Achieve Efficient Tumor Delivery and Therapeutic Effect in an EGFRpos Mouse Xenograft ModelSimon Huet, Magali Zeisser Labouebe, Rute Castro, et al.
Scientific Reports|March 22, 2025
Complete preclinical evaluation of the novel antibody mimetic Nanofitin-IRDye800CW for diverse non-invasive diagnostic applications in the management of HER-2 positive tumorsMargherita Iaboni, Federico Crivellin, Francesca Arena, et al.
Scientific Reports|December 19, 2025
Investigating probe-receptor interactions and enhancing fluorescence guided surgery with fluorescence lifetime imaging and NF-800 in HER-2 positive esophageal adenocarcinomaFrancesca La Cava, Francesca Arena, Daniele Faletto, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Research in Structural Biology|January 19, 2026
Molecular determinants of TNFR1:TNFα binding and dynamics in a physiological membrane environmentElena Álvarez Sánchez, Simon Huet, Stéphane Téletchéa
Journal of Molecular Recognition : JMR|December 15, 2025
Energetics Decomposition of Sac7d:DNA Decrypts Amino Acids Role Without DNA Sequence SelectivityElena Álvarez-Sánchez, Bernard Offmann, Simon Huet, et al.
Plos One|November 6, 2015
Use of the Nanofitin Alternative Scaffold as a GFP-Ready Fusion TagSimon Huet, Harmony Gorre, Anaëlle Perrocheau, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 31, 2023
Inhalable Nanofitin demonstrates high neutralization of SARS-CoV-2 virus via direct application in respiratory tractSébastien Viollet, Elise Enouf, Justine Picot, et al.
Pharmaceutics|January 23, 2024
Enhancing Oral Delivery of Biologics: A Non-Competitive and Cross-Reactive Anti-Leptin Receptor Nanofitin Demonstrates a Gut-Crossing Capacity in an Ex Vivo Porcine Intestinal ModelSolene Masloh, Anne Chevrel, Maxime Culot, et al.
Journal of the American Chemical Society|March 17, 2026
Phenotyping by Molecular Mobility: Low-Affinity Reversible Probes Enable Characterizing and Classifying Cells Populations by Single-Molecule ImagingRoger Riera, Laurence W Fitzpatrick, Simon Huet, et al.
Molecular Cancer Therapeutics|August 14, 2023
Targeted Nanofitin-drug Conjugates Achieve Efficient Tumor Delivery and Therapeutic Effect in an EGFRpos Mouse Xenograft ModelSimon Huet, Magali Zeisser Labouebe, Rute Castro, et al.
Scientific Reports|March 22, 2025
Complete preclinical evaluation of the novel antibody mimetic Nanofitin-IRDye800CW for diverse non-invasive diagnostic applications in the management of HER-2 positive tumorsMargherita Iaboni, Federico Crivellin, Francesca Arena, et al.
Scientific Reports|December 19, 2025
Investigating probe-receptor interactions and enhancing fluorescence guided surgery with fluorescence lifetime imaging and NF-800 in HER-2 positive esophageal adenocarcinomaFrancesca La Cava, Francesca Arena, Daniele Faletto, et al.
Pageof 1